EPIX
ESSA Pharma Inc.
ESSA Pharma Inc. (EPIX) is currently in a downtrend, trading below both the 50-day and 200-day moving averages. RSI is at 15.7 (oversold), with 0/3 trend checks passing.
EPIX with MA50 and MA200
Key levels & signals
ESSA Pharma Inc. (EPIX) currently looks weaker on the chart and is not showing much trend strength. The latest available price is $0.20, and 0 of 3 core trend checks are currently passing. Price is trading below the 50-day moving average by 74.9% and below the 200-day moving average by 86.4%.
EPIX currently has an RSI reading of 15.7, which places it in a deeply oversold zone. That can sometimes lead to bounce-watch setups, but it can also reflect genuine weakness, so the chart still needs proper confirmation rather than hope alone.
For traders reviewing EPIX next, the main question is whether weakness is starting to stabilise or whether the chart still looks vulnerable to further downside. Some traders may watch for bounce attempts, but others will want to see stronger proof that the trend is improving before treating the stock as a cleaner setup.
About ESSA Pharma Inc.
ESSA Pharma Inc. (EPIX) functions as a clinical-stage pharmaceutical firm, concentrating its efforts on developing innovative and exclusive therapies designed to combat prostate cancer. The company's primary drug candidate is EPI-7386, an oral treatment presently undergoing Phase I clinical trials. This investigational compound is intended for individuals suffering from metastatic castration-resistant prostate cancer. Furthermore, ESSA Pharma has established collaborative partnerships with organizations including Caris Life Sciences, Inc., Bayer Consumer Care AG, Janssen Research & Development, LLC, and Astellas Pharma Inc. Founded in 2009, the company's corporate offices are located in Vancouver, Canada.
EPIX shares outstanding over time
Tracking total shares outstanding is one way to spot dilution — a rising line means the company has issued more shares (stock-based compensation, secondary offerings, convertible debt), which spreads the same earnings and ownership across more shares. A falling line usually reflects buybacks.
Learn the indicators behind this page
More stock opportunities
Common questions about EPIX
Is this page a buy or sell recommendation?
No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.
Why can a stock look bullish and overbought at the same time?
Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.
What should I do next after reading this page?
Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.